605008.SH
长鸿高科
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 13.21
+2.09%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.0B | 3.9B | 3.6B | 1.4B | 2.4B |
| Cost of Revenue | 3.7B | 3.6B | 3.3B | 1.3B | 2.0B |
| Gross Profit | 292.3M | 290.0M | 334.3M | 158.1M | 390.9M |
| Operating Expenses | |||||
| R&D Expense | 132.6M | 126.6M | 117.7M | 55.1M | 86.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 67.6M | 65.8M | 49.6M | 39.3M | 38.6M |
| Selling & Marketing Expense | 20.9M | 16.9M | 13.3M | 19.1M | 16.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 350.9M | 326.9M | 263.9M | 174.7M | 203.7M |
| Cost and Expenses | 4.1B | 4.0B | 3.6B | 1.4B | 2.2B |
| Operating Income (EBIT) | (30.6M) | (24.9M) | 96.8M | 103.2M | 192.3M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (31.4M) | (22.0M) | 96.7M | 104.0M | 189.4M |
| Income Tax Expense | (10.7M) | (13.8M) | 2.6M | 9.1M | 9.0M |
| Bottom Line | |||||
| Net Income | (20.4M) | (8.0M) | 94.2M | 95.0M | 180.5M |
| Earnings from Cont. Ops | (20.6M) | (8.2M) | 94.0M | 94.9M | 180.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (20.4M) | (8.0M) | 94.2M | 95.0M | 180.5M |
| Per Share | |||||
| Basic EPS | (CN¥0.02) | (CN¥0.01) | CN¥0.15 | CN¥0.15 | CN¥0.28 |
| Diluted EPS | (CN¥0.02) | (CN¥0.01) | CN¥0.15 | CN¥0.15 | CN¥0.28 |
| Revenue Per Share | CN¥5.55 | CN¥4.91 | CN¥5.78 | CN¥2.24 | CN¥3.68 |
| Shares | |||||
| Basic Shares Outstanding | 721.4M | 798.6M | 628.2M | 633.4M | 644.5M |
| Diluted Shares Outstanding | 721.4M | 798.6M | 628.2M | 633.4M | 644.5M |
| Profitability Metrics | |||||
| EBITDA | — | 184.3M | 256.6M | 239.5M | 321.8M |
| D&A | — | 209.2M | 159.9M | 136.4M | 129.6M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026